Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- New Blood Test Decides The Type of Cancer Treatmenton July 3, 2021 at 5:36 am
The blood test detecting changes in DNA specific to cancer ensure a more personalized approach to treatment and improve cancer care.
- Flinders University trial to evaluate new blood test for personalized cancer treatmenton July 1, 2021 at 10:04 am
A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway.
- Blood test for personalized cancer treatmenton June 30, 2021 at 9:00 pm
A blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The trial is thanks to a federal government ...
- Can a blood test diagnose cancer?on June 29, 2021 at 6:00 pm
Blood tests can help check for many health indicators. However, can they test for cancer? Find out whether there is a single blood test for cancer.
- New blood test can detect more than 50 types of cancer, researchers sayon June 29, 2021 at 1:37 pm
Researchers say a new blood test, called Galleri, is effective at finding over 50 cancers that often go undetected in their early stages. The test offers a promising look into the future, when new ...
- How blood tests are transforming cancer treatmenton June 28, 2021 at 8:30 am
Four years ago, researchers in the CRUK TRACERx team at the Crick and UCL, alongside an industry-collaborator Natera, developed a personalized test that uses circulating fragments of tumor DNA (ctDNA) ...
- Pre-symptom blood test that detects more than 50 cancers rolled outon June 25, 2021 at 10:36 am
The test, developed by California-based company Grail Inc., is called Galleri and is now available in the US by prescription only.
- Study says cancer blood test accurate enough to screen for diseaseon June 25, 2021 at 8:19 am
Scientists have concluded that a simple blood test that can detect 50 types of cancer -- even before the onset of typical signs of the diseases -- is accurate enough to be used as a screening test for ...
- Blood Test for Many Cancer Types as Supplement to Screeningon June 25, 2021 at 3:07 am
New results for the Galleri blood test, which can detect more than 50 types of cancer, support its use as an adjunct to standard screening, say researchers.
- Blood test for early detection of cancer: final study results support screening useon June 25, 2021 at 12:17 am
Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher ...
via Bing News